radiopharmaceuticals

You have access
¹⁸F FDG PET/CT Prediction of Treatment Outcomes in HPV-positive, Locally Advanced Oropharyngeal Cancer Receiving De-intensified Therapy: Results from NRG-HN002
Rathan M Subramaniam, Lyudmila DeMora, Min Yao, Sue S Yom, Maura Gillison, Jimmy J Caudell, John Waldron, Ping Xia, Christine Chung, Minh Tam Truong, Michelle Echevarria, Jason W Chan, Jessica L Geiger, Loren Mell, Samantha Seaward, Wade L Thorstad, Jonathan Jay Beitler, Khalil Sultanem, Diagjin Blakaj and Quynh-Thu Le

Journal of Nuclear Medicine September 2, 2022, jnumed.122.264424; DOI: https://doi.org/10.2967/jnumed.122.264424
You have access
Comparison of ⁶⁸Ga-PSMA-617 PET/CT and ⁶⁸Ga-RM2 PET/CT in patients with localized prostate cancer candidate for radical prostatectomy: a prospective, single arm, single center, phase II study
Romain Schollhammer, Grégoire Robert, Julien Asselineau, Mokrane Yacoub, Delphine Vimont, Nicolas Balamoutoff, Franck Bladou, Antoine Bénard, Elif Hindié, Henri H de Clermont-Gallerande and Clément Morgat

Journal of Nuclear Medicine September 2, 2022, jnumed.122.263889; DOI: https://doi.org/10.2967/jnumed.122.263889
You have access
Pretargeting: A Path Forward for Radioimmunotherapy
Sarah M. Cheal, Sebastian K. Chung, Brett A. Vaughn, Nai-Kong V. Cheung and Steven M. Larson

Journal of Nuclear Medicine September 1, 2022, 63 (9) 1302-1315; DOI: https://doi.org/10.2967/jnumed.121.262186
Open Access
First-in-Human Evaluation of Safety and Dosimetry of ⁶⁴Cu-LLP2A for PET Imaging
Richard Laforest, Anchal Ghai, Tyler J. Fraum, Reiko Oyama, Jennifer Frye, Helen Kaemmerer, Greg Gaehle, Thomas Voller, Cedric Mpoy, Buck E. Rogers, Mark Fiala, Kooresh I. Shoghi, Samuel Achilefu, Michael Rettig, Ravi Vij, John F. DiPersio, Sally Schwarz, Monica Shokeen and Farrokh Dehdashti

Journal of Nuclear Medicine August 25, 2022, jnumed.122.264349; DOI: https://doi.org/10.2967/jnumed.122.264349
You have access
Investigating Tau and Amyloid Tracer Skull Binding in Studies of Alzheimer disease
Shaney Flores, Charles D. Chen, Yi Su, Aylin Dincer, Sarah J. Keefe, Nicole S. McKay, Angela M. Paulick, Gloria Guzman Perez-Carillo, Liang Wang, Russ C. Hornbeck, Manu Goyal, Andrei Vlassenko, Sally Schwarz, Michael L. Nickels, Dean F. Wong, Zhude Tu, Jonathan E. McConathy, John C. Morris, Tammie L.S. Benzinger and Brian A. Gordon

Journal of Nuclear Medicine August 11, 2022, jnumed.122.263948; DOI: https://doi.org/10.2967/jnumed.122.263948
You have access
Nanobody theranostics on the horizon
Weijun Wei, Muhsin Younis, Xiaoli Lan, Jianjun Liu and Weibo Cai

Journal of Nuclear Medicine July 14, 2022, jnumed.122.263907; DOI: https://doi.org/10.2967/jnumed.122.263907
Open Access
A Novel Experimental Generator for Production of High Purity Lead-212 for Use in Radiopharmaceuticals
Ruth Gong Li, Vilde Yuli Stenberg and Roy Hartvig Larsen

Journal of Nuclear Medicine July 7, 2022, jnumed.122.264009; DOI: https://doi.org/10.2967/jnumed.122.264009
Open Access
Estimating the risk for secondary cancer following targeted alpha therapy with astatine-211 intraperitoneal radioimmunotherapy
Erik Leidermark, Andreas Hallqvist, Lars Jacobsson, Per Karlsson, Erik Holmberg, Tom Bäck, Mia Johansson, Sture Lindegren, Stig Palm and Per Albertsson

Journal of Nuclear Medicine July 7, 2022, jnumed.121.263349; DOI: https://doi.org/10.2967/jnumed.121.263349
You have access
Whole-body PET imaging in humans shows that ¹¹C-PS13 is selective for cyclooxygenase-1 and can measure the in vivo potency of nonsteroidal anti-inflammatory drugs
Min-Jeong Kim, Fernanda Juarez Anaya, Lester S Manly, Jae-Hoon Lee, Jinsoo Hong, Stal Shrestha, Sanjay Telu, Katharine Henry, Jose A Montero Santamaria, Jeih-San Liow, Paolo Zanotti-Fregonara, H. Umesha Shetty, Sami S Zoghbi, Victor W. Pike and Robert B. Innis

Journal of Nuclear Medicine July 7, 2022, jnumed.122.264061; DOI: https://doi.org/10.2967/jnumed.122.264061
You have access
Proceedings: PET Drugs—A Workshop on Inspections Management and Regulatory Considerations
Sue Bunning, Christopher Ignace, Steve Mattmuller, Sally W. Schwarz, Peter J.H. Scott, Henry F. VanBrocklin, Steven S. Zigler and on behalf of the Coalition of Drug Manufacturers

Journal of Nuclear Medicine July 1, 2022, 63 (7) 1117-1123; DOI: https://doi.org/10.2967/jnumed.121.263443

Main menu

User menu

Search

radiopharmaceuticals

Pages